A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention Article

sustainable development goals

publication date

  • May 27, 2024

webpage

published in

keywords

  • HIV prevention
  • elvitegravir
  • microbicide
  • rectal insert
  • tenofovir alafenamide

start page

  • 696

end page

  • 705

volume

  • 230

issue

  • 3